We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


New Model Could Improve Design of Vaccines and Immunotherapies

New Model Could Improve Design of Vaccines and Immunotherapies content piece image
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

The body’s immune system defeats diseases by sensing foreign invaders, like bacteria or viruses, and then mounting a response against them.

But just how immune cell receptors work together to sense multiple molecules and make these decisions remained a mystery. Now, researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have discovered a general property for understanding how these cells sense and respond to microbial signals.

By studying how molecules impact immune cells, they found that while the effect of a single molecule does not predict the effect of two molecules together, the complexity stops there. In fact, the effect of singles and pairs of molecules can be used to predict how triplets of molecules work.

The study, led by Asst. Prof. Nicolas Chevrier and published October 27 in the journal Cell Systems, led to a more effective cancer immunotherapy in mice and could lead to more effective vaccines for both existing and novel viruses.

Key to designing vaccines

Each of the body’s innate immune cells has receptors that recognize molecules from foreign pathogens. To fight off bacteria or viruses, those cells make decisions in response to complex combinations of inputs from those molecules. Though researchers have studied singular pathways, how these pathways work together is still not well understood.

Chevrier and his collaborators set out to better understand how cells integrate multiple signals into a response. Not only would it help answer a basic fundamental question of biology, it would also help design vaccines that use adjuvants, molecules that help modulate the immune system and enhance its response.

Though just a few vaccines currently use them, adjuvants might be the key to developing new kinds of vaccines. Right now, FDA-approved adjuvants target only one or two of the cell’s receptors. If researchers could find the right combination to target more, vaccines could become more effective.

Understanding how combinations work together

Chevrier and his collaborators used adjuvants to stimulate immune cells in petri dishes to figure out what happens when single molecules, pairs of molecules, and triplets of molecules are used. If the results were additive, the effects of one molecule and the effects of another molecule would, when combined, remain the same. Researchers found that wasn’t the case—two molecules combined led to different effects than each had singularly.

But they did find that the effect of single molecules and pairs of molecules could accurately predict what happened with triplets of molecules.

“It could have been infinitely complex, but it’s not,” Chevrier said. “We are the first to show you can predict higher-order effects across immune pathways with very simple models.”

Model used to design cancer immunotherapy

To prove their theory, the researchers injected cells conditioned with certain combinations of adjuvants—creating a specific cancer immunotherapy treatment—in a mouse model with tumors. The response was potent: the tumors grew five to ten times less in treated mice versus untreated mice.

Reference: Pandey S, Gruenbaum A, Kanashova T, et al. Pairwise Stimulations of Pathogen-Sensing Pathways Predict Immune Responses to Multi-adjuvant Combinations. Cell Syst . 2020. doi:10.1016/j.cels.2020.10.001

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.